Structure–activity studies on seco-pancratistatin analogs: Potent inhibitors of human cytochrome P450 3A4

Structure–activity studies on seco-pancratistatin analogs: Potent inhibitors of human cytochrome P450 3A4 Potent and selective inhibition of human cytochrome P450 3A4 by seco-pancratistatin structural analogs Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model Synthesis and Biological Evaluation of Fully Functionalized seco-Pancratistatin Analogues Human Cytochrome P450 Liability Studies of trans-Dihydronarciclasine: A Readily Available, Potent, and Selective Cancer Cell Growth Inhibitor A synthesis of 3-deoxydihydrolycoricidine: Refinement of a structurally minimum pancratistatin pharmacophore 3- and 4-Pyridylalkyl Adamantanecarboxylates:  Inhibitors of Human Cytochrome P450₁₇_α <b>(17</b>α-Hydroxylase/C_17,20-Lyase). Potential Nonsteroidal Agents for the Treatment of Prostatic Cancer Cytochrome P450 1 enzyme inhibition and anticancer potential of chromene amides from Amyris plumieri Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety